Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protoco
(Q73806740)
scientific article published on 01 May 2000
scientific article published on 01 May 2000
Language:
other details
description | scientific article published on 01 May 2000 |
External Links
(P356) |
10.1002/1529-0131(200005)43:5<978::AID-ANR4>3.0.CO;2-0
|
(P698) |
10817549
|